Silencing of HMGA2 by siRNA Loaded Methotrexate Functionalized Polyamidoamine Dendrimer for Human Breast Cancer Cell Therapy
Open Access
- 20 July 2021
- Vol. 12 (7), 1102
- https://doi.org/10.3390/genes12071102
Abstract
The transcription factor high mobility group protein A2 (HMGA2) plays an important role in the pathogenesis of some cancers including breast cancer. Polyamidoamine dendrimer generation 4 is a kind of highly branched polymeric nanoparticle with surface charge and highest density peripheral groups that allow ligands or therapeutic agents to attach it, thereby facilitating target delivery. Here, methotrexate (MTX)- modified polyamidoamine dendrimer generation 4 (G4) (G4/MTX) was generated to deliver specific small interface RNA (siRNA) for suppressing HMGA2 expression and the consequent effects on folate receptor (FR) expressing human breast cancer cell lines (MCF-7, MDA-MB-231). We observed that HMGA2 siRNA was electrostatically adsorbed on the surface of the G4/MTX nanocarrier for constructing a G4/MTX-siRNA nano-complex which was verified by changing the final particle size and zeta potential. The release of MTX and siRNA from synthesized nanocomplexes was found in a time- and pH-dependent manner. We know that MTX targets FR. Interestingly, G4/MTX-siRNA demonstrates significant cellular internalization and gene silencing efficacy when compared to the control. Besides, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay demonstrated selective cell cytotoxicity depending on the folate receptor expressing in a dose-dependent manner. The gene silencing and protein downregulation of HMGA2 by G4/MTX-siRNA was observed and could significantly induce cell apoptosis in MCF-7 and MDA-MB-231 cancer cells compared to the control group. Based on the findings, we suggest that the newly developed G4/MTX-siRNA nano-complex may be a promising strategy to increase apoptosis induction through HMGA2 suppression as a therapeutic target in human breast cancer.Funding Information
- Tabriz University of Medical Sciences (57701)
This publication has 48 references indexed in Scilit:
- Dendrimers as Carriers for siRNA Delivery and Gene Silencing: A ReviewThe Scientific World Journal, 2013
- Molecular Mechanisms of RNA InterferenceAnnual Review of Biophysics, 2013
- Cancer Genes in Lung Cancer: Racial Disparities: Are There Any?Genes & Cancer, 2012
- Elucidating the molecular mechanism of PAMAM–siRNA dendriplex self-assembly: Effect of dendrimer charge densityInternational Journal of Pharmaceutics, 2011
- Methotrexate delivery via folate targeted dendrimer‐based nanotherapeutic platformWIREs Nanomedicine and Nanobiotechnology, 2009
- Association of a Weakly Acidic Anti-Inflammatory Drug (Ibuprofen) with a Poly(Amidoamine) Dendrimer as Studied by Molecular Dynamics SimulationsThe Journal of Physical Chemistry B, 2009
- HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinomaLaboratory Investigation, 2008
- HMGA2 Participates in Transformation in Human Lung CancerMolecular Cancer Research, 2008
- Lucifer's Labyrinth—Ten Years of Path Finding in Cell DeathMolecular Cell, 2007
- siRNAs: applications in functional genomics and potential as therapeuticsNature Reviews Drug Discovery, 2004